ESSO Course on the Management of High Risk Patients for Breast Cancer. A Multidisciplinary Approach

Transcription

1 ESSO Course on the Management of High Risk Patients for Breast Cancer. A Multidisciplinary Approach February 2016 BERLIN (DE)

2 ESSO Course on the Management of High Risk Patients for Breast Cancer. A Multidisciplinary Approach Chairs Tibor Kovacs, Guy s and St. Thomas Hospital, London, UK Isabel Teresa Rubio, Hospital Universitario Vall d Hebrón, Barcelona, SP Faculty members Antonis Antoniou, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK Andrew Baildam, Barts and The London Hospitals, Queen Mary, University of London, London, UK Serena Di Cosimo, Istituto Nazionale dei Tumori, Milan, IT Anju Kulkarni, Guy s and St. Thomas Hospital, London, UK Roel Mus, Radboud University Medical Center, Radboud, NL Sarah Pinder, King s College London, London, UK Marc Thill, Agaplesion Markus Hospital, Frankfurt, DE Lynda Wyld, Sheffield University, Sheffield, UK

3 Aim of the course This course will provide a comprehensive multidisciplinary approach to the theory and practice of the management of patients with increased risk for developing breast cancer. The goal will be to provide evidence based and up-to-date information on all aspects of care for those with a higher than average level of risk for developing breast cancer. The programme will address topics from basic science through risk assessment to complex clinical management and risk reduction strategies and will explore in depth the understanding of risk models, risk prediction, management of BRCA mutation positive, negative patients and those with contralateral breast cancer risk including surveillance, medical and surgical risk reduction strategies. The course will deliver a practical, workshop-based approach for surgeons and clinicians providing them with the scientific evidence and information to help their patients to reach informed decisions about their future. Educational Methods Clinical case discussions Plenary lectures Ideal course candidates Oncoplastic breast and plastic surgeons General surgery trainees with breast interest Specialist residents and trainees in breast surgery, surgical oncology Specialist breast surgeons with traditional training Gynecologists Course Coordination Ana Galán European Society of Surgical Oncology (ESSO) . ana.galan@essoweb.org

4 Course venue Arcotel John F Berlin Werderscher Markt 11, Berlin, Germany Accommodation For accommodation please contact the course coordinator Participation fee To ensure interactivity during the course, attendance is limited to 30 participants. The participation fee is 400 for ESSO members and 550 for non-esso members. It includes registration to the course, catering and a social dinner. Application Procedure To apply please go to the course webpage at Accreditation An application for accreditation has been submitted to the European Accreditation Council for CME (EACCME) of the European Union of Medical Specialists (UEMS)

5 Programme Friday 5 th February MOLECULAR BASES OF HEREDITARY BREAST CANCER 13:45-14:00 Welcome and introduction T. Kovacs, I. T. Rubio 14:00-14:30 BRCA and beyond - what else needs to be tested? A. Antoniou 14:30-15:00 Understanding risk models for breast cancer L. Wyld 15:00-16:00 Clinical cases discussion Who to test L. Wyld, A. Antoniou 16:00-16:15 Coffee break 16:15-16:45 Defining hight risk breast lesions and impact on breast cancer development S. Pinder 16:45-17:15 Surgical management of high risk lesions - LCIS, ADH, ALH, FEA I. T. Rubio 17:15-17:45 Imaging and follow up on high risk patients - LCIS, ADH, ALH, FEA R. Mus 19:30 Social dinner

6 Programme Saturday 6 th February HIGH RISK PATIENTS NO MUTATION CARRIERS/ BRCA NEGATIVE 08:00-08:30 Management of BRCA negative and non-tested patients demanding risk reduction strategies A. Kulkarni 08:30-09:30 Clinical cases S. Pinder, I. T. Rubio, R. Mus, A. Kulkarni 09:30-10:00 How to run a multidisciplinary BRCA clinic and MDT A. Baildam 10:00-10:15 Coffee break 10:15-10:45 Genetic testing at the surgical oncologist clinic I. T. Rubio 10:45-11:15 Risk reduction strategies for BRCA carriers. When is it time to start? A. Kulkarni 11:15-11:45 Long term surveillance of BRCA mutation carriers and patients with higher risk of developing, breast cancer R. Mus 11:45-12:45 Breast cancer risk reduction strategies: Medical Oncology- Chemoprevention S. Di Cosimo 12:45-13:15 Lunch BRCA MUTATION CARRIERS Surgical options-radical risk reduction strategies; the risk reduction mastectomy (NSM, SSM) T. Kovacs Options for immediate reconstruction A. Baildam 13:15-13:45 Risk of ovarian cancer and prophylactic surgery M. Thill 13:45-14:15 Mutation carriers with breast cancer: breast conservative surgery vs bilateral mastectomy T. Kovacs, I. T. Rubio

7 14:15-14:45 Breast cancer and fertility M. Thill 14:45-15:00 Coffee break 15:00-15:40 Clinical cases A. Baildam, S. Di Cosimo, T. Kovacs, M. Thill 15:40-16:40 Consensus Statement on Prophylactic Mastectomy

8 ESSO is grateful for the continuous support of its corporate sponsors European Society of Surgical Oncology (ESSO) Avenue E. Mounier 83 B 1200 Brussels Tel: +32 (0) Fax : +32 (0) info@essoweb.org Website :